MMMark Mujer

Mark Mujer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mark Mujer has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antithrombin Supplementation in Adults with Acute Lymphoblastic Leukemia (ALL) Following Asparaginase Therapy: A Meta-Analysis

    by Osama Mosalem, Mark Mujer, Fawzi Abu Rous, Craig E. Cole

    Background: Aspagarinase is a fundamental component for the treatment of patients with acute lymphoblastic leukemia (ALL). Venous thromboembolism (VTE) is a known complication of asparaginase therapy during treatment for ALL. This is attributed to the depletion of anticoagulants, particularly acquired antithrombin deficiency following asparaginase administration. The incidence of thrombosis following asparaginase is more prevalent in adults versus children and is estimated to be around 5-35 % and 2.4-8% respectively. Multiple studies have investigated the efficacy and safety of antithrombin supplementation. The recent THROMBOTECT study showed that prophylactic use of antithrombin (AT) or low molecular weight heparin (LMWH) is associated with significant risk reduction of thromboembolism in children and adolescents during induction chemotherapy of ALL. Our study sought to review the cohort studies comparing VTE in adults with and without AT supplementation in ALL receiving asparaginase and specifically evaluate the efficacy of this strategy. Methods: We performed a systematic search using PubMed, Google Scholar, EMBASE, SCOPUS and ClinicalTrials.gov without language restriction up until July 20th 2020. A random effects model was utilized to calculate risk ratio (RR) and mean difference (MD) with 95% confidence interval (CI). Results: Eight studies fulfilled our inclusion criteria (table 1) and were retrospective cohort studies. In adult patients, with ALL treated with asparaginase, the incidence of VTE was significantly lower in those who received AT [RR=0.46 (95 % CI= 0.31-0.70; p= 0.0002) (figure 1.1). The threshold for AT supplementation was 60-70% in most of the studies, with the exception of two studies where the threshold was 50%. Conclusion: In our meta-analysis of the current available data,Antithrombin supplementation in adults with ALL receiving asparaginase was associated with a significant decrease in the risk of venous thromboembolism compared to those who didn't receive thromboprophylaxis. Our data suggest the benefit of antithrombin supplementation in adults with ALL treated with asparaginase. We suggest that this strategy be implemented in a large prospective clinical trial to further confirm the benefit of this intervention. Disclosures: No relevant conflicts of interest to declare.


  • Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome

    by Abdullah Al-Abcha, Yehia Saleh, Mark Mujer, Manel Boumegouas, Khader Herzallah, Lawrenshey Charles, Layan Elkhatib, Ola Abdelkarim, Michael Kehdi, George S. Abela


  • A comparison of figure‐of‐8‐suture versus manual compression for venous access closure after cardiac procedures: An updated meta‐analysis

    by Mark Terence Mujer, Abdullah Al‐Abcha, Jairus Flores, Yehia Saleh, Peter Robinson

    Background Manual compression (MC) is the current standard to achieve postprocedural hemostasis in patients who need venous vascular access closure after cardiovascular procedures. Figure‐of‐8 (F8) suture for venous access closure has been reported to be a safe and efficacious alternative to MC. Methods A systematic search was done using PubMed, Google Scholar, EMBASE, SCOPUS, and ClinicalTrials.gov without language restriction up until April 15, 2020 for studies comparing F8 suture versus MC. Risk ratio (RR) and mean difference (MD) with 95% confidence interval (CI) were calculated using a random effects model. Results Time to achieve hemostasis was significantly reduced in the F8 arm [MD −21.04 min (95% CI: −35.66 to −6.42; P = .005)]. Access site bleeding was significantly lower in the F8 group [RR 0.35 (95% CI: 0.18 to 0.66; P = .001)] along with a lower incidence of hematoma formation [RR 0.42 (95% CI: 0.26 to 0.67; P = .0003)]. There was no significant difference in rates of fistula or pseudoaneurysm formation between the two groups. Overall access site complications were lower in the F8 arm [RR 0.38 (95% CI: 0.26 to 0.55; P < .00001)] and the effect was more pronounced for sheaths ≥10 Fr [RR 0.33 (95% CI: 0.18 to 0.60; P = .0003)]. There was lower postprocedural protamine use in the F8 group [RR 0.07 (95% CI: 0.01 to 0.36; P = .001)]. Conclusion For large‐bore venous access closure, the F8 suture results in a shortened time to achieve hemostasis along with a lower overall risk of access site complications and postprocedural protamine use.


  • Effect of combined renal denervation and pulmonary vein isolation in atrial fibrillation recurrence in hypertensive patients: A meta‐analysis

    by Mark Terence Mujer, Abdullah Al‐Abcha, Yehia Saleh, Lakshmi Akhila Nerusu, Manel Boumegouas, Khader Herzallah, Kai Chen

    Background: Atrial Fibrillation (AF) is the most common cardiac arrhythmia and hypertension is the most common risk factor associated with AF. The addition of renal sympathetic nerve denervation (RSDN) to pulmonary vein isolation (PVI) in AF patients with hypertension has been reported to improve clinical outcomes.Methods: A systematic search was performed for studies on patients with AF and hypertension that compared RSDN with PVI versus PVI‐alone. Risk ratio (RR) for categorical variables and mean difference (MD) for continuous variables with 95% confidence intervals were used.Results: Seven studies with a total of 734 patients were included. A total of 340 patients were in the RSDN + PVI group (46.32%) and 394 (53.67%) in the PVI group. A total of 608 patients had paroxysmal AF (83%) while 126 patients had persistent AF (17%). At 12 months follow‐up, RSDN + PVI decreased the overall risk of AF recurrence in hypertensive patients with RR 0.60 [95% CI 0.50‐0.72, P < .00001]. A subgroup analysis performed in patients with drug‐resistant hypertension showed a similar reduction in AF recurrence with RR 0.61 [95% CI: 0.47‐0.79, P = .0002). Procedure duration MD + 28.05 min [95% CI: 18.88‐37.23, P < .00001] and fluoroscopy duration MD + 5.59 min [95% CI: 3.31‐8.19, P < .00001] were significantly longer with the RSDN + PVI group. There was no significant difference in complications between the two groups.Conclusion: The addition of RSDN to PVI in patients with AF and hypertension appears safe and decreases AF recurrence. Similar results were observed in patients with drug‐resistant hypertension. Larger trials are needed to confirm these results.


  • Rarecase of biventricular thrombi complicating pulmonary embolism

    by Mark Mujer, Samanjit Kaur Kandola, Yehia Saleh, Khader Herzallah

    A 70-year-old man with a history of chronic lymphocytic leukaemia (CLL) in remission, hypertension, dyslipidaemia and active smoking presented with a 2-week history of non-productive cough, progressive shortness of breath and right lower extremity swelling. On presentation, the patient was


  • Pulmonary embolism with right ventricular thrombus: a management dilemma

    by Mark Mujer, Yehia Saleh, Calvin Abro, Samanjit Kaur Kandola

    A woman in her 80s with Alzheimer’s disease presented with dyspnoea and chest pain. The patient had a heart rate of 109, respiratory rate of 24 and was hypoxic, needing 4 L of oxygen supplementation. Blood pressure was at 142/78 which was her baseline. Physical examination showed an anxious


  • Overutilisation of imaging studies for diagnosis of pulmonary embolism: are we following the guidelines?

    by Prajwal Dhakal, Mian Harris Iftikhar, Ling Wang, Varunsiri Atti, Sagar Panthi, Xiao Ling, Mark T P Mujer, Om Dawani, Manoj P Rai, Shilpa Tatineni, et al.

    Objective To evaluate if imaging studies such as CT pulmonary angiography (CTPA) or ventilation–perfusion (V/Q) scan are ordered according to the current guidelines for the diagnosis of pulmonary embolism (PE). Methods We performed a retrospective observational cohort study in all adult patients who presented to the Sparrow Hospital Emergency Department from January 2014 to December 2016 and underwent CTPA or V/Q scan. We calculated the Wells’ score retrospectively, and d-dimer values were used to determine if the imaging study was justified. Results A total of 8449 patients underwent CTPA (93%) or V/Q scan (7%), among which 142 (0.2%) patients were diagnosed with PE. The Wells’ criteria showed low probabilities for PE in 96 % and intermediate or high probabilities in 4 % of total patients. Modified Wells’ criteria demonstrated PE unlikely in 99.6 % and PE likely in 0.4 % of total patients. D-dimer was obtained in only 37 % of patients who were unlikely to have a PE or had a low score on Wells’ criteria. Despite a low or unlikely Wells’ criteria score and normal d-dimer levels, 260 patients underwent imaging studies, and none were diagnosed with PE. Conclusion More than 99 % of CTPA or V/Q scans were negative in our study. This suggests extraordinary overutilisation of the imaging methods. D-dimer, recommended in patients with low to moderate risk, was ordered in only one-third of patients. Much greater emphasis of current guidelines is needed to avoid inappropriate utilisation of resources without missing diagnosis of PE.


  • Open Access

    Paget-Schroetter syndrome

    by Ardy Fenando, Mark Mujer, Manoj P Rai, Ahmad Alratroot


  • Open Access

    Spontaneous rupture of a pancreatic pseudocyst

    by Mark Tp Mujer, Manoj P Rai, Varunsiri Atti, Shiva Shrotriya


  • Open Access

    Emphysematous Osteomyelitis

    by Mark Tp Mujer, Manoj P Rai, Mohamed Hassanein, Subhashis Mitra